RePORT International Highlights
These are important RePORT International resources.
60 items found
Funding
NOFO: Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): April 07, 2025; Expiration Date: January 08, 2028
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding
NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding
NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028
Award Budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year.
Award Project Period may not exceed 2 years.
Funding
Patient-Centered Outcomes Research Institute: Phased Large Awards for Comparative Effectiveness Research PCORI Funding Announcement
DEADLINE FOR LETTER OF INTENT: 28 April 2026; 5 pm (ET)
DEADLINE FOR APPLICATION:1 September 2026; 5 pm (ET)
This PCORI Funding Announcement (PFA) invites applications for high impact patient-centered comparative clinical effectiveness research (CER) projects that will address critical decisions faced by patients, families, caregivers, clinicians, and the health and healthcare community and for which there is insufficient evidence. Investigators must propose an individual-level or cluster randomized controlled trial of significant scale and scope for this PFA. The proposed trials should address critical decisional dilemmas that require important new evidence about the comparative clinical effectiveness of available interventions. Proposed studies should compare interventions that already have robust evidence of efficacy and are in current use. If efficacy is not well established, then widespread use must be documented. Clinical interventions (such as medications, diagnostic tests, or procedures) and delivery system interventions (such as workforce, technologies and healthcare service delivery designs) are appropriate for these studies.
Please refer to the website for the details.
Funding
PCORI: Improving Methods for Conducting Patient-Centered Comparative Clinical Effectiveness Research
The Patient-Centered Outcomes Research Institute (PCORI) aims to fund studies that address high-priority methodological gaps in patient-centered comparative clinical effectiveness research (CER). Awards will provide up to $750,000 over a period of up to three years.
Funding
Pediatric Infectious Diseases Society: Fellowship and Research Awards
The PIDS Foundation is pleased to offer annual fellowships and research awards to fellows and faculty. The goal of the PIDS award program is to increase the pool of highly trained pediatric infectious disease clinical scientists and to stimulate scholarly basic, translational, and clinical research in areas pertinent to Pediatric Infectious Diseases, including innovative research to improve or develop new vaccines and immunotherapeutics for children.
Please refer to the websites for the details on various fellowships.
Research Tools
RSTMH journals: Call for Reviewers
The Royal Society of Tropical Medicine and Hygiene (RSTMH) journals, International Health and Transactions of the Royal Society of Tropical Medicine & Hygiene are currently recruiting new reviewers to help the author community improve their papers and ensure the integrity of that we publish research. Reviewers provide feedback to authors that helps make their paper stronger.
The RSTMH is a charity and membership society that has been dedicated to improving tropical medicine and global health since 1907. Our ambition is to save lives and improve health around the world through increased access to and greater equity in global healthcare.
Who can become a reviewer?
You can be at any stage of your research career, provided you can objectively evaluate the quality and rigour of a research paper. We welcome reviewers from all countries. We also encourage collaborative reviews, where senior researchers review papers in collaboration with junior lab members (note, this must be disclosed in the ‘Confidential Comments to the Editor’ section of the reviewer report form).
How to volunteer to be a reviewer?
If you are interested in reviewing for us, please send a copy of your CV via email to Thomas.pinfield@rstmh.org, along with a short statement which outlines your research interests/expertise.
Research Tools
Sabin Vaccine Institute - Boost Community
Boost offers comprehensive training opportunities for immunization professionals that are both adaptive and technical. Our adaptive trainings pair with a specific immunization topic (e.g., life course immunization) and focus on building, developing and deepening leadership skills for community organizing. Graduates of our advanced training develop the capacity to deliver their own training to the Boost Community or within their own communities. The Stop TB Partnership is a supporting partner.
Funding
Searle Scholars Program
The Searle Scholars Program makes grants to selected universities and research institutes to support the independent research of exceptional young faculty in the biomedical sciences and chemistry.
Searle Scholars Award Grants are set at $450,000 for a three-year period with $150,000 payable each year.
Participating institutions may nominate outstanding early-career scientists to apply for the program.
Applications are accepted annually from June through September, only through an online application system.
Please refer to the website for the details.
Funding
The German Central Committee against (DZK e.V.) - Media Award on Tuberculosis
DEADLINE FOR SUBMISSION: 31 October 2026
The German Central Committee against (DZK e.V.) is looking for the best media work on the subject of tuberculosis. The prize, worth €2,500, recognizes contributions that make a significant contribution to understanding the disease and combating it.
Journalistic works (print, TV, film, radio, online) and artistic projects in German or relevant to the German-speaking world are welcome. publications the years 2024 to 2026 can be submitted. The prerequisites for an award are current relevance and medical and factual accuracy of the presentation.
The award ceremony will take place in March 2027 during the TB AKTUELL conference in Berlin.
Training & Conferences
The Union-North America Region (NAR) - Annual TB Conference 2027
Abstract, Travel Grant, and Challenging Case Submissions Now Open
Deadline for Submissions: 21 September 2026
February 24 – 28, 2027 | Vancouver, BC, Canada
The 2027 End TB Conference of the Union North American Region is looking forward to holding its 31st annual conference at the Sheraton Vancouver Wall Centre Hotel, 1000 Burrard St, Vancouver, BC, Canada, from February 24-27, 2027. We hope that you will join us in person to participate in our pre-conference postgraduate sessions and stay to attend our full conference. Please visit our website for ongoing conference program updates as we finalize our agenda over the next few months. We look forward to seeing to both new and familiar faces in support of the North American TB community.
Training & Conferences
The Union: World Health Conference on Lung Health 2026
The Union World Conference on Lung Health brings together researchers, practitioners, advocates, policymakers and communities from around the world to share knowledge, exchange ideas and accelerate progress in lung health.
Rio de Janeiro, Brazil; 17–20 November 2026
Please refer to the website for registrations, program information and key dates
Funding
The University of Washington (SEATRAC): Advanced TB Training Course
September 21-25, 2026 - 10:30 am-2:30 pm (ET)
Format: Virtual
Cost: $100 (fee waived for LMIC attendees)
This one-week intensive course is designed for students, trainees, faculty, clinicians, and early-career TB researchers seeking to develop knowledge and skills in both theory and methods to advance TB research.
Funding
Tropical Medicines and Infectious Disease Journal: Young Investigator Awards
DEADLINE FOR NOMINATION: 31 December 2026
Winner announcement: 30 April 2027
Eligibility and Requirements
– Must have received their PhD no more than 10 years prior to 31 December 2026;
– Must have produced ground-breaking research and made a significant contribution to the advancement of healthcare and sustainable development;
– Must be nominated by senior scientists.
List of Documents for Nomination
– Detailed Curriculum Vitae, including an updated publication list and a list of the researcher’s own research grants;
– Scanned copy of doctorate certificate;
– Signed nomination letters from two established senior scientists.
Training & Conferences
Union North America Region (UNION NAR) Conference 2027
DEADLINE FOR SUBMISSION: 21 September 2026
DATE and LOCATION: February 24-27, 2027, Vancouver, BC, Canada
Please refer to the website in detials for:
Call for Abstracts
Call for Challenging Cases "New"
Travel Grant Information
Funding
University of Washington: Postdoctoral Scholar (Mycobacteria pathogenesis and spatial biology)
We are seeking a Postdoctoral Scholar with interests in mycobacterial pathogenesis, spatial immunology, and global health to join the Sabo and Shah Labs in the University of Washington Division of Allergy & Infectious Diseases. The Sabo Lab is focused on identifying factors that contribute to infectious diseases in mucosal spaces, including Mycobacteria leprae, the causative agent of leprosy. The Shah lab is focused on pathogenesis of mycobacterial diseases. We perform detailed studies using specimens derived from human samples. This project is focused on developing the most detailed atlas of immune factors in leprosy granulomas conducted to date, and will be conducted in a collaborative effort between the Sabo and Shah labs.
Please refer to the website for the details.
Additional TB Resources
Upskill TB - a free online learning platform
RePORT Indonesia, in partnership with the TB Alliance and the Respiratory Programmatic and Research Institute, have developed Upskill TB, a free online learning platform designed to enhance knowledge and skills in the treatment and management of drug-resistant tuberculosis. The current version has expert-led courses on the innovative BPaL/M regimen.
Funding
Warrwn Alpert Foundation: Warren Alpert Foundation Prize
The mission of the Warren Alpert Foundation Prize is to recognize and honor one or more scientists whose scientific achievements have led to the prevention, cure, or treatment of human disorders or for seminal research that holds great promise to change our ability to treat disease.
Nominations are accepted from physicians and scientists from around the world. U.S. and non-U.S. citizens are eligible to be nominated.
Self-nominations are not accepted.
Nominees must be living.
Up to five nominees may be co-nominated in one nomination.
Multiple nominations from an institution are permitted.
Funding
WashU Medicine Division of General Medicine & Geriatrics: General Internal Medicine Research Fellowships
The GIM Research Fellowship at WashU Medicine embeds physician-scientists in active research. Fellows train in one of four tracks (Global Health, Implementation Science, Clinical and Health Services Research, or Clinical Operations and Quality), earn a graduate certificate or master’s degree, and launch independent academic careers.
Funding
Weiss Asset Management Foundation: Programs and Research to Alleviate Human Suffering
Deadline: Rolling
Weiss Asset Management Foundation invites proposals from organizations and researchers that engage in highly cost-effective work to alleviate human suffering in low- and lower-middle-income countries. Most grants will range from approximately $50,000 to $1.5 million. There is no lower bound, and in exceptional circumstances, grants may exceed $1.5 million.